If a patient has Morton’s neuroma , formulate and evaluate an assessment and management plan for the patients presentation worth eight marks, provide the clinical working diagnosis with one mark, what gait alterations may be observed in patients worth three marks, designs and evaluate a foot orthosis for the management of the patients presentation worth five marks, include this LO1 - Formulate and evaluate evidence-based podiatric assessment and management plans for a range of musculoskeletal disorders commonly encountered within podiatry clinics LO2 - Analyse methods of gait analysis and identify how these can be used in the assessment of common musculoskeletal conditions. LO3 - Evaluate the use of orthoses in the management of foot health
"Morton neuroma" AND treatment
"Morton neuroma" AND orthosis AND gait
"Morton neuroma" AND gait AND foot
- Marks 1–2: Thorough subjective history with symptom characterisation and PROMs
- Marks 3–4: Objective examination — Mulder's sign, neurological/vascular screen, differential diagnosis
- Mark 5: Appropriate investigations (X-ray, USS, MRI) with rationale
- Marks 6–7: Stepwise evidence-based management (footwear → orthosis → injection → ESWT → surgery)
- Mark 8: Critical evaluation of evidence, including the Cochrane 2024 review on injections
- Mark 1: Antalgic/guarded propulsive phase with shortened stride
- Mark 2: Lateral weight transfer and COP deviation with pedobarographic rationale
- Mark 3: Reduced cadence, gait analysis methods (OGA, pedobarography, 3D capture)
- Marks 1–2: Orthosis specification (material, length, dome positioning — with precise anatomical justification)
- Mark 3: Rearfoot posting for pronation control and its biomechanical reasoning
- Marks 4–5: Critical evaluation of effectiveness, evidence limitations, review protocol, and integration into the management ladder